国际泌尿系统杂志
國際泌尿繫統雜誌
국제비뇨계통잡지
INTERNATIONAL JOURNAL OF UROLOGY AND NEPHROLOGY
2014年
1期
55-57
,共3页
碎石术%生活质量
碎石術%生活質量
쇄석술%생활질량
Lithotripsy%Quality of Life
目的 探讨索利那新联合坦索罗辛对改善双J管相关症状的疗效.方法 79例输尿管镜碎石术后留置双J管患者随机分为治疗组和对照组.对照组常规治疗,治疗组在常规治疗基础上每天加用索利那新5mg及坦索罗辛0.2mg共4周.4周后拔除双J管,同时完成国际前列腺症状评分(IPSS)、生活质量评分(QOL)、视觉模拟评分(VAS).结果 全部患者完成研究,无严重并发症发生.对照组中IPSS总分、IPSS刺激评分、IPSS储尿评分、QOL评分、VAS评分分别为(13.56±5.10)、(7.23±3.50)、(6.33±2.55)、(2.75±1.26)、(2.88±1.64),治疗组为(7.26±3.20)、(4.15±2.16)、(3.11±2.07)、(1.40±1.23)、(2.03±1.35),差异均有统计学意义(P＜0.05).结论 索利那新联合坦索罗辛能有效改善患者因留置双J管引起的相关症状,提高生活质量.
目的 探討索利那新聯閤坦索囉辛對改善雙J管相關癥狀的療效.方法 79例輸尿管鏡碎石術後留置雙J管患者隨機分為治療組和對照組.對照組常規治療,治療組在常規治療基礎上每天加用索利那新5mg及坦索囉辛0.2mg共4週.4週後拔除雙J管,同時完成國際前列腺癥狀評分(IPSS)、生活質量評分(QOL)、視覺模擬評分(VAS).結果 全部患者完成研究,無嚴重併髮癥髮生.對照組中IPSS總分、IPSS刺激評分、IPSS儲尿評分、QOL評分、VAS評分分彆為(13.56±5.10)、(7.23±3.50)、(6.33±2.55)、(2.75±1.26)、(2.88±1.64),治療組為(7.26±3.20)、(4.15±2.16)、(3.11±2.07)、(1.40±1.23)、(2.03±1.35),差異均有統計學意義(P＜0.05).結論 索利那新聯閤坦索囉辛能有效改善患者因留置雙J管引起的相關癥狀,提高生活質量.
목적 탐토색리나신연합탄색라신대개선쌍J관상관증상적료효.방법 79례수뇨관경쇄석술후류치쌍J관환자수궤분위치료조화대조조.대조조상규치료,치료조재상규치료기출상매천가용색리나신5mg급탄색라신0.2mg공4주.4주후발제쌍J관,동시완성국제전렬선증상평분(IPSS)、생활질량평분(QOL)、시각모의평분(VAS).결과 전부환자완성연구,무엄중병발증발생.대조조중IPSS총분、IPSS자격평분、IPSS저뇨평분、QOL평분、VAS평분분별위(13.56±5.10)、(7.23±3.50)、(6.33±2.55)、(2.75±1.26)、(2.88±1.64),치료조위(7.26±3.20)、(4.15±2.16)、(3.11±2.07)、(1.40±1.23)、(2.03±1.35),차이균유통계학의의(P＜0.05).결론 색리나신연합탄색라신능유효개선환자인류치쌍J관인기적상관증상,제고생활질량.
Objectives To evaluate the efficacy of solifenacin and tamsulosin in improving double-J stent related urinary tract symptoms.Methods A total of 79 patients with double-J stent placement following ureteroscopic lithotripsy were randomized into two groups.The treated group received 5 mg solifenacin and 0.2 mg tamsulosin once daily for 4 weeks,and the control group received routine treatment.All patients were asked to complete the Intemational Prostate Symptom Score(IPSS),quanlity of life (QOL) and visual analogue scale (VAS) 4 weeks post -operatively when the double-J stent was removed.Results All patients finished the studies.The total IPSS score,irritative IPSS score,obstructive IPSS score,Qol and VAS score were all significantly different between the two groups(P ＜0.05).Total IPSS score:(13.56 ±5.10) vs(7.26 ±3.20) ; irritative IPSS score:(7.23 ±3.50)vs (4.15 ± 2.16) ; obstructive IPSS score:(6.33 ± 2.55) vs (3.11 ± 2.07) ; QOL:(2.75 ± 1.26) vs (1.40 ± 1.23) ; VAS score:(2.88 ± 1.64) vs (2.03 ± 1.35).Conclusions Administration of solifenacin and tamsulosin for patients with an interal double-J stent can relieve stent-related symptoms and improve quality of life.
